Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Modulation of gene expression by the MHC class II transactivator.

Nagarajan UM, Bushey A, Boss JM.

J Immunol. 2002 Nov 1;169(9):5078-88.

2.

Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.

Kanaseki T, Ikeda H, Takamura Y, Toyota M, Hirohashi Y, Tokino T, Himi T, Sato N.

J Immunol. 2003 May 15;170(10):4980-5.

3.

Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.

Liu A, Takahashi M, Toba K, Zheng Z, Hashimoto S, Nikkuni K, Furukawa T, Koike T, Aizawa Y.

Hematol Oncol. 1999 Dec;17(4):149-60.

PMID:
10725870
4.

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B.

Science. 1994 Jul 1;265(5168):106-9.

PMID:
8016643
6.

Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.

Piskurich JF, Gilbert CA, Ashley BD, Zhao M, Chen H, Wu J, Bolick SC, Wright KL.

Mol Immunol. 2006 Feb;43(6):519-28. Epub 2005 Jun 13.

7.

TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.

Lee YJ, Han Y, Lu HT, Nguyen V, Qin H, Howe PH, Hocevar BA, Boss JM, Ransohoff RM, Benveniste EN.

J Immunol. 1997 Mar 1;158(5):2065-75.

PMID:
9036950
8.

Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter.

Deffrennes V, Vedrenne J, Stolzenberg MC, Piskurich J, Barbieri G, Ting JP, Charron D, Alcaïde-Loridan C.

J Immunol. 2001 Jul 1;167(1):98-106.

9.
10.

DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cells.

Murphy SP, Holtz R, Lewandowski N, Tomasi TB, Fuji H.

J Immunol. 2002 Sep 15;169(6):3085-93.

11.

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.

Morimoto Y, Toyota M, Satoh A, Murai M, Mita H, Suzuki H, Takamura Y, Ikeda H, Ishida T, Sato N, Tokino T, Imai K.

Br J Cancer. 2004 Feb 23;90(4):844-52. Erratum in: Br J Cancer. 2004 Nov 29;91(11):1978.

12.

Induction of MHC class I expression by the MHC class II transactivator CIITA.

Martin BK, Chin KC, Olsen JC, Skinner CA, Dey A, Ozato K, Ting JP.

Immunity. 1997 May;6(5):591-600.

13.
14.

CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.

Meissner M, Whiteside TL, Kaufmann R, Seliger B.

Arch Dermatol Res. 2009 Feb;301(2):189-93. doi: 10.1007/s00403-008-0922-6. Epub 2008 Dec 23.

PMID:
19104823
15.

Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.

Radosevich M, Jager M, Ono SJ.

Exp Mol Pathol. 2007 Feb;82(1):68-76. Epub 2006 May 2.

PMID:
16650406
16.

Quantitative control of MHC class II expression by the transactivator CIITA.

Otten LA, Steimle V, Bontron S, Mach B.

Eur J Immunol. 1998 Feb;28(2):473-8.

17.

Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator.

Pai RK, Askew D, Boom WH, Harding CV.

J Immunol. 2002 Aug 1;169(3):1326-33.

18.
19.

Supplemental Content

Support Center